Results for tag: "Intracerebral Hemorrhage Drug"

Intracerebral Hemorrhage (ICH) is a type of stroke caused by bleeding within the brain. It is a life-threatening medical emergency and requires prompt treatment. Drugs used to treat ICH include anticoagulants, antiplatelet agents, thrombolytics, and vasopressors. Anticoagulants are used to reduce the risk of further bleeding, while antiplatelet agents are used to prevent the formation of blood clots. Thrombolytics are used to dissolve existing clots, while vasopressors are used to reduce blood pressure. The Intracerebral Hemorrhage Drug market is a subset of the Central Nervous System Drugs market. It is a rapidly growing market, driven by the increasing prevalence of stroke and other neurological disorders. The market is highly competitive, with a number of large pharmaceutical companies competing for market share. Some of the major companies in the Intracerebral Hemorrhage Drug market include Pfizer, Merck, GlaxoSmithKline, Sanofi, Novartis, and Johnson & Johnson. Show Less Read more